Key facts
- GB Soft’s last known valuation is $39.9M (Jan 2025).
- It has raised $8.6M; the latest was Later Stage VC ($5.5M) in Jan 2025.
- Notable investors include Tech Incubator Program for Startup, Y&Archer, Comes Investment, HB Investment, IPS Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for GB Soft
- ·The full record, as it builds
Funding rounds
No funding rounds for GB Soft are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GB Soft
Developer of AI-based non-contact biosignal measurement solutions designed to facilitate remote health monitoring and improve safety across industrial, mobility, and medical sectors. The company utilizes rPPG (remote photoplethysmography) technology and computer vision to instantly measure pulse, oxygen saturation, blood pressure, and stress levels through standard device cameras, enabling healthcare providers, vehicle manufacturers, and industrial operators to seamlessly monitor vital signs without wearable sensors, optimize patient care, and ensure continuous personal safety.
- Sector
- Healthcare
- HQ
- Daegu, South Korea
- Founded
- 2017
- Employees
- 38
- Website
- gb-soft.co.kr/
- Ownership
- Privately Held (backing)
GB Soft doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GB Soft shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GB Soft in its N-PORT filings yet. We sweep new filings monthly.